Your browser doesn't support javascript.
loading
A toolbox of immunoprecipitation-grade monoclonal antibodies to human transcription factors.
Venkataraman, Anand; Yang, Kun; Irizarry, Jose; Mackiewicz, Mark; Mita, Paolo; Kuang, Zheng; Xue, Lin; Ghosh, Devlina; Liu, Shuang; Ramos, Pedro; Hu, Shaohui; Bayron Kain, Diane; Keegan, Sarah; Saul, Richard; Colantonio, Simona; Zhang, Hongyan; Behn, Florencia Pauli; Song, Guang; Albino, Edisa; Asencio, Lillyann; Ramos, Leonardo; Lugo, Luvir; Morell, Gloriner; Rivera, Javier; Ruiz, Kimberly; Almodovar, Ruth; Nazario, Luis; Murphy, Keven; Vargas, Ivan; Rivera-Pacheco, Zully Ann; Rosa, Christian; Vargas, Moises; McDade, Jessica; Clark, Brian S; Yoo, Sooyeon; Khambadkone, Seva G; de Melo, Jimmy; Stevanovic, Milanka; Jiang, Lizhi; Li, Yana; Yap, Wendy Y; Jones, Brittany; Tandon, Atul; Campbell, Elliot; Montelione, Gaetano T; Anderson, Stephen; Myers, Richard M; Boeke, Jef D; Fenyö, David; Whiteley, Gordon.
Afiliação
  • Venkataraman A; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Yang K; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Irizarry J; CDI Laboratories, Mayaguez, PR, USA.
  • Mackiewicz M; HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.
  • Mita P; Institute for System Genetics, NYU Langone Health, New York, New York, USA.
  • Kuang Z; Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, New York, USA.
  • Xue L; Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Ghosh D; Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, New York, USA.
  • Liu S; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Ramos P; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Hu S; Department of Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Bayron Kain D; CDI Laboratories, Mayaguez, PR, USA.
  • Keegan S; CDI Laboratories, Mayaguez, PR, USA.
  • Saul R; CDI Laboratories, Mayaguez, PR, USA.
  • Colantonio S; Institute for System Genetics, NYU Langone Health, New York, New York, USA.
  • Zhang H; Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, New York, USA.
  • Behn FP; Department of Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Song G; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA.
  • Albino E; Department of Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Asencio L; HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.
  • Ramos L; Department of Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Lugo L; CDI Laboratories, Mayaguez, PR, USA.
  • Morell G; CDI Laboratories, Mayaguez, PR, USA.
  • Rivera J; CDI Laboratories, Mayaguez, PR, USA.
  • Ruiz K; CDI Laboratories, Mayaguez, PR, USA.
  • Almodovar R; CDI Laboratories, Mayaguez, PR, USA.
  • Nazario L; CDI Laboratories, Mayaguez, PR, USA.
  • Murphy K; CDI Laboratories, Mayaguez, PR, USA.
  • Vargas I; CDI Laboratories, Mayaguez, PR, USA.
  • Rivera-Pacheco ZA; CDI Laboratories, Mayaguez, PR, USA.
  • Rosa C; CDI Laboratories, Mayaguez, PR, USA.
  • Vargas M; CDI Laboratories, Mayaguez, PR, USA.
  • McDade J; CDI Laboratories, Mayaguez, PR, USA.
  • Clark BS; CDI Laboratories, Mayaguez, PR, USA.
  • Yoo S; CDI Laboratories, Mayaguez, PR, USA.
  • Khambadkone SG; Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • de Melo J; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Stevanovic M; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Jiang L; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Li Y; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Yap WY; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Jones B; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Tandon A; Eukaryotic Tissue Culture Facility, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Campbell E; CDI Laboratories, Mayaguez, PR, USA.
  • Montelione GT; NeoBiotechnologies, Inc., Union City, California, USA.
  • Anderson S; NeoBiotechnologies, Inc., Union City, California, USA.
  • Myers RM; Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey, USA.
  • Boeke JD; Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey, USA.
  • Fenyö D; Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey, USA.
  • Whiteley G; Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey, USA.
Nat Methods ; 15(5): 330-338, 2018 05.
Article em En | MEDLINE | ID: mdl-29638227
ABSTRACT
A key component of efforts to address the reproducibility crisis in biomedical research is the development of rigorously validated and renewable protein-affinity reagents. As part of the US National Institutes of Health (NIH) Protein Capture Reagents Program (PCRP), we have generated a collection of 1,406 highly validated immunoprecipitation- and/or immunoblotting-grade mouse monoclonal antibodies (mAbs) to 737 human transcription factors, using an integrated production and validation pipeline. We used HuProt human protein microarrays as a primary validation tool to identify mAbs with high specificity for their cognate targets. We further validated PCRP mAbs by means of multiple experimental applications, including immunoprecipitation, immunoblotting, chromatin immunoprecipitation followed by sequencing (ChIP-seq), and immunohistochemistry. We also conducted a meta-analysis that identified critical variables that contribute to the generation of high-quality mAbs. All validation data, protocols, and links to PCRP mAb suppliers are available at http//proteincapture.org.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Análise Serial de Proteínas / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Nat Methods Assunto da revista: TECNICAS E PROCEDIMENTOS DE LABORATORIO Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Análise Serial de Proteínas / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Nat Methods Assunto da revista: TECNICAS E PROCEDIMENTOS DE LABORATORIO Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos